Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-6.9%1-day move

₹343.00

prior close

₹345.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.2-1.4-1.2-1.3-6.9+0.6+3.3+3.7+3.8+4.2+7.2+11.3+14.1+9.3

Up moveDown movePending

AI summary

Aarti Drugs Limited has informed the stock exchanges that its trading window will remain closed from April 1, 2026, until 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026. This is a routine compliance measure required under SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, insiders, directors, and designated employees are restricted from trading in the company's shares. The communication was signed by Rushikesh Deole, Company Secretary and Compliance Officer.

Likely market impact

This is a standard regulatory filing and has no direct impact on the stock price or business. It signals that the company is preparing to announce its Q4 and full-year FY26 results soon, and restricts insider trading during that sensitive period.